[1] LEE JS,HAYASHI K,MISHRA G,et al.Independent association between age at natural menopause and hypercholesterolemia,hypertension and diabetes mellitus:Japan nurses,health dtudy[J].J Atheroscler Thromb,2013,20(2):161-169.
|
[2]XU J,AI LY,LUO F,et al.The analysis on the risk factors of non-alcoholic fatty liver disease in public health personnel in Beijing[J].Capit J Public Health,2012,6(1):6-10.(in Chinese)许嘉,艾丽艳,罗凤,等.北京市某区卫生防疫人群非酒精性脂肪肝危险因素分析[J].首都公共卫生,2012,6(1):6-10.
|
[3]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
|
[4] SOCHA P,WIER BICKA A,NEUHOFF-MURAWSKA J,et al.Nonalcocholic fatty liver disease as a feature of the metalolic syndrome[J].Rocz Pocz Panstw Zakl Hig,2007,58(1):129-137.
|
[5]CARR MC.The emergence of the metabolic syndrome with menopause[J].J Clin Endocrinol Metab,2003,88(6):2404-2414.
|
[6]CAI W,HE FP,WU X,et al.The associaion of serum uric acid level with prevalence of non-alcoholic fatty liver in Uyghur and Han Ethnicities[J].Chin J Endocrinol Metab,2012,28(1):890-894.(in Chinese)蔡雯,何方平,吴璇,等.维吾尔族、汉族非酒精性脂肪肝与血尿酸的相关性研究[J].中华内分泌代谢杂志,2012,28(1):890-894.
|
[7]SONG XX,WU L,CHEN Y,et al.Analysis of related factors influencing Xinjiang Uygur insulin resistance[J/CD].Chin J Clinicians:Electronic Edition,2014,8(19):3466-3468.(in Chinese)宋向欣,吴岚,陈园,等.影响新疆维吾尔族人群胰岛素抵抗的相关因素分析[J/CD].中华临床医师杂志:电子版,2014,8(19):3466-3468.
|
[8] HOSC,WU S,CHAN SG,et al.Menopausal transition and changes of body composition:aprospective study in Chinese perimenopausal women[J].Int J Obes,2010,34(80):1265-1274.
|
[9]ZHENG X,ZHAO W,ZHANG XH,et al.Association between nonhigh-density lipoprotein cholesterol level and non-alcoholic fatty liver disease in patients with type 2 diabetes.(in Chinese)郑晓,赵伟,张晓会,等.2型糖尿病患者非高密度脂蛋白胆固醇水平与非酒精性脂肪肝的相关性研究[J].实用医学杂志,2014,30(3):437-439.
|
[10]ASSY N,KATIA K,MYMIN D,et al.Fatty infiltration of liver in hyperlipidemic patients[J].Dig Dis Sci,2000,45(10):1929-1934.
|
[11]JI XL,GE YD,AN MM,et al.Clinical correlation analysis between nonalcoholic fatty liver disease and metabolic syndrome[J].Chin JClin Pharmacol Ther,2014,19(6):666-670.(in Chinese)季学磊,葛艺东,安民民,等.非酒精性脂肪肝与代谢综合征的临床相关性分析[J].中国临床药理学与治疗学,2014,19(16):666-670.
|
[12]BUDOFF MJ,YOUNG R,LOPEZ VA,et al.Progression of coronary calcium and incident coronary heart diseaseevents:MESA(Multi-Ethnic Study of therosclerosis)[J].J Am Coll Cardiol,2013,61(2):1231-1239.
|
[13]XIN GQ,TANG Y,TANG XF,et al.Study of correlation between serum uric acid level and prevalence of nonalcoholic fatty liver[J].Med J Natl Defending Forces Southwest China,2010,20(12):1295-1297.(in Chinese)辛国秋,唐悦,唐先富.血清尿酸水平与非酒精性脂肪肝发病的相关性研究[J].西南国防医药,2010,20(12):1295-1297.
|
[14]LEI JY.Association between serum uric acid and non-high-density lipoprotein cholesterol[J].Zhejiang Clin Med J,2008,10(7):987-988.(in Chinese)雷静月.血尿酸与非高密度脂蛋白胆固醇关系的分析[J].浙江临床医学,2008,10(7):987-988.
|
[15]ZALAWADIYA SK,VEERANNA V,PANAICH S,et al.Nonhigh-density lipoprotein cholesterol and coronary artery calcium progressionin a multiethnic US population[J].Am J Cardiol,2014,11(3):471-474.
|
[16]FRONTINI MG,SRINIVASAN SR,XU JH,et al.Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults(the Bogalusa Heart Study)[J].Am J Cardiol,2007,100(1):64-68.
|
[17]LI YP,MA RL,ZHANG M,et al.Epidemic features of dyslipidemia among Uygur,Kazakh,and Han adults in Xinjiang[J].Chin J Prevent Med,2013,47(10):949-952.(in Chinese)李亚鹏,马儒林,张眉,等.新疆维吾尔族、哈萨克族及汉族成年人血脂异常的流行特点[J].中华预防医学杂志,2013,47(10):949-952.
|
[18]FU WJ,PENG LF,YE CQ,et al.Relationship between non-HDL-C and other lipid indices[J].Int J Lab Med,2007,28(8):705-707.(in Chinese)付文金,彭兰芬,叶长钦,等.非高密度脂蛋白胆固醇与传统血脂指标的相关性分析[J].国际检验医学杂志,2007,28(8):705-707.
|
[19]LYU SR,SU J,XIANG QY,et al.The association of triglyceride and high-density lipoprotein cholesterol ratio withinsulin resistance among Chinese adults[J].Chin J Prev Contr Chron Dis,2014,22(6):641-643.(in Chinese)吕淑荣,苏健,向全永,等.甘油三酯和高密度脂蛋白胆固醇比值与胰岛素抵抗的关系[J].中国慢性病预防与控制,2014,22(6):641-643.
|
[1] | Chenlu ZHAO, Suping MA, Dongfang SHANG, Sutong LIU, Xiaoyan LIU, Yuanyuan ZHENG, Wenxia ZHAO. Association of menopausal time and menopausal age with nonalcoholic fatty liver disease: An analysis based on a restricted cubic spline model[J]. Journal of Clinical Hepatology, 2025, 41(2): 247-253. doi: 10.12449/JCH250209 |
[2] | Jiang DENG, Zhiyi HAN, Cailan XIAO, Yating SUN, Yajun JI, Li AO, Yonghong ZHANG, Xiaolan LU. Prevalence rate of non-obese fatty liver disease and related influencing factors[J]. Journal of Clinical Hepatology, 2021, 37(11): 2600-2604. doi: 10.3969/j.issn.1001-5256.2021.11.022 |
[3] | Wenqian XU, Yaoqi WU, Jinyuan ZHANG, Tianchuang YANG, Heguo LI, Min GUO. Mechanism of estrogen against liver fibrosis in postmenopausal women with chronic liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2425-2428. doi: 10.3969/j.issn.1001-5256.2021.10.035 |
[4] | Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044 |
[5] | Ren DanDan, Liu Na, Zhou LuLu, Zhang Nan, Li ChunXia, Dong Bing, Xu GuangHua. Risk factors for hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(7): 1634-1638. doi: 10.3969/j.issn.1001-5256.2020.07.041 |
[6] | Shu YunRan, Li JunQi, Liu Qiong. Epidemiology of nonalcoholic fatty liver disease and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2085-2090. doi: 10.3969/j.issn.1001-5256.2019.09.045 |
[7] | Sun MiaoMiao, Cao LiYing, Sun WeiDong, Liu XiNing, Cui HaoZhe, Liang MingYang, Wei YaoChen, Wang WanChao, Liu SiQing. Association of serum high-density lipoprotein cholesterol with new-onset cholelithiasis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1745-1750. doi: 10.3969/j.issn.1001-5256.2019.08.019 |
[8] | Feng Gong, Mi Man, Li XuePing, He Na, Chen ZiJun, Niu ChunYan. The economic burden and risk factors in inflammatory bowel disease with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(12): 2702-2706. doi: 10.3969/j.issn.1001-5256.2018.12.042 |
[9] | Chen QinQin, Liang CanCan, Yang LiJun, Meng Qing, Ding YongNian. A clinical analysis of Uygur patients with acute ischemic cerebral infarction complicated by nonalcoholic fatty liver disease in Urumqi, China[J]. Journal of Clinical Hepatology, 2018, 34(6): 1259-1263. doi: 10.3969/j.issn.1001-5256.2018.06.025 |
[10] | Zhao HongXin, Yan Rong, Niu ChunYan, Zhou YongLi, Wang Jia, Cao RuiQi. Prevalence and associated risk factors for obesity and nonalcoholic fatty liver disease in adolescents in Xi′an, Shaanxi province, China[J]. Journal of Clinical Hepatology, 2015, 31(8): 1248-1251. doi: 10.3969/j.issn.1001-5256.2015.08.016 |
[11] | Cai Wen, Dong ZhengHui, Wang ShuXia, Yang XiaoPing, Yao Hua. Analysis of correlation between serum 25- hydroxyvitamin D level and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(7): 1059-1062. doi: 10.3969/j.issn.1001-5256.2015.07.015 |
[12] | Qiao LiNa, Dai GuangRong, Zhang Jin, Shen Ni. An epidemiological survey of prevalence and risk factors for fatty liver disease in adults residing in Yan'an,China[J]. Journal of Clinical Hepatology, 2015, 31(1): 82-87. doi: 10.3969/j.issn.1001-5256.2015.01.018 |
[13] | Lin Wei, Si JianLin, Zhang Jian, Maimaitijiang·Wubuliaishan, Hu ZhiMing, Li DongZeng, Geng Nan. Pegylated interferon alpha-2a combined with ribavirin for chronic hepatitis C: a clinical analysis of 160 patients of Uygur nationality or Han nationality[J]. Journal of Clinical Hepatology, 2015, 31(11): 1831-1836. doi: 10.3969/j.issn.1001-5256.2015.11.015 |
[14] | Zhang Jian. Correlation between malnutrition and prognosis of hepatitis A in Uygur children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1235-1237. doi: 10.3969/j.issn.1001-5256.2015.08.013 |
[15] | Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304. |
[16] | Chen YongFang, Wu ZhanJun. Pathogenesis and risk factors of cholesterol gallstones in patients with non- alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 952-955. doi: 10.3969/j.issn.1001-5256.2013.12.021 |
[17] | Wu Tao, Yin ShouYi, Wang HongZhang, Zhang Hong, Jia Wei, Ji Guang. The clinical features and risk factors of patient with metabolic syndrome combined with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(10): 1036-1040. |
[18] | Zhang YiNing, Du HongWei, Liu YanJun, Wang ChaoXia. The diagnosis and risk factors for evaluation of nonalcoholic fatty liver disease in children and adolescents[J]. Journal of Clinical Hepatology, 2011, 27(7): 690-693. |
[19] | Wan Hong, Li Ling, Tang YanPing. study on fatty liver prevalence in the government officers in Lanzhou area[J]. Journal of Clinical Hepatology, 2008, 24(4): 261-262. |
[20] | Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45. |
1. | 廖雪姣,张丽娜,李轩,董京科,黄国仪. 绝经后女性非酒精性脂肪性肝病患者性激素水平与胰岛素抵抗 肝酶学异常的关系. 山西医药杂志. 2019(14): 1658-1659 . ![]() | |
2. | 丁智勇,卜乐,鲁鸿燕,饶正轩. 非酒精性脂肪性肝病患者血清维生素A水平、肝脏脂肪含量与胰岛素抵抗的相关性分析. 临床肝胆病杂志. 2017(12): 2361-2365 . ![]() |